I honestly don’t think i’ve twisted anything at all. If we’re going by the slides they used to illustrate the full process, it’s clear that NDAs/CDAs are a couple of steps before dataroom access. It’s uncharacteristically bullish of you to suggest all of those companies who signed NDA’s then submitted non-binding offers.
- Forums
- ASX - By Stock
- PAR
- The Ghosh Study - PART 1
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.00%
!
38.5¢

The Ghosh Study - PART 1, page-40
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
38.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $153.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7594 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 4500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7594 | 0.395 |
2 | 5360 | 0.390 |
8 | 62572 | 0.385 |
4 | 19472 | 0.380 |
2 | 33333 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 4500 | 1 |
0.390 | 1199 | 1 |
0.395 | 151898 | 1 |
0.400 | 50000 | 1 |
0.405 | 18626 | 1 |
Last trade - 09.45am 31/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |